Biomarker detection using layered receptor and electrode configuration
AssigneeMindMend Biotech LLC
InventorsMercedes Terry, Blair Dupre, Abigail Tubbs, Kiley House, Jude Shupe
Life of this patent
Estimating the term…
Loading patent…
AssigneeMindMend Biotech LLC
InventorsMercedes Terry, Blair Dupre, Abigail Tubbs, Kiley House, Jude Shupe
Estimating the term…
Herein disclosed is configuring a layered receptor with at least one layer comprising graphene oxide and an biomarker binding layer configured to bind with a targeted biomarker, connecting a working electrode comprising carbon nanotubes (CNT) and a reference electrode to the layered receptor, and detecting events comprising the targeted biomarker binding layer with the biomarker binding layer, by measuring changes in impedance to a plurality of frequencies of an alternating current voltage signal applied through a patient's body fluid between the working electrode and the reference electrode. The layered receptor may further comprise a plurality of self-assembled layers, comprising, in sequence, a layer abutting the CNT and comprising a polymer and metal nanoparticles, a layer comprising an organosulfur, the graphene oxide layer and the biomarker binding layer. The biomarker binding layer may comprise Syn-211, LB509 or 5G4. The targeted biomarker may be alpha-synuclein. An implementation may report biomarker concentrations in real-time based on detected binding events.
A method for measuring biomarker levels comprising:
A biosensor comprising:
Dependencies are inferred from the claim text.